ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 597

Investigating the Genetic Association Between ERAP1 and Spondyloarthritis

Amir Kadi1, Brigitte Izac2, Roula Said-Nahal3, Ariane Leboime4, Kurt L. de Vlam5, Dirk Elewaut6, Gilles Chiocchia2 and Maxime A. Breban3, 1Institut Cochin - Université Paris Descartes - INSERM U1016 - CNRS (UMR 8104), Paris, France, 2Immunology and Hematology Department, Institut Cochin - INSERM U1016 - CNRS (UMR 8104), Paris, France, 3Rheumatology Division, Ambroise Paré Hospital (AP-HP), and Versailles Saint Quentin en Yvelines University, Boulogne-Billancourt, France, 4Rheumatology Division, Ambroise-Paré Hospital AP-HP, Boulogne-Billancourt, France, 5Rheumatology, University Hospitals Leuven, Leuven, Belgium, 6Rheumatology, Department of Rheumatology Ghent University Hospital, Ghent, Belgium

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), polymorphism and spondylarthropathy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondylarthritis and Psoriatic Arthritis - Pathogenesis, Etiology

Session Type: Abstract Submissions (ACR)

Background/Purpose:  A robust association was recently identified between polymorphisms in the non-major histocompatibility complex gene ERAP1 and ankylosing spondylitis (AS) in several populations. The aim of the current study was to determine the level of association of ERAP1 polymorphisms with spondyloarthritis (SpA) in French/Belgian population with a particular attention to genotype-phenotype correlations.

Methods:  We studied 734 independent SpA cases and 632 controls from 2 European cohorts. Five single nucleotide polymorphisms (SNPs), rs27044, rs17482078, rs10050860, rs30187 and rs2287987 were genotyped and case-control association analyses were carried using PLINK. Linkage disequilibrium and haplotypes were estimated with Haploview. Analysis was first carried in SpA as a whole group, and then separately in AS and non-radiographic SpA (non-AS) patients.

Results: Consistent with previous studies conducted in AS, rs30187 was the most significantly associated SNP with SpA (P=0.008 in the French and P=6.46×10−4 in the Belgian cohorts). In the combined cohort, this SNP was associated with both AS and non-AS (PCombined=3.9×10−5 and PCombined=0.005, respectively). A similar trend was observed with other SNPs. The rs17482078/rs10050860/rs30187-CCT haplotype was significantly associated with increased risk of SpA in both cohorts (Pcombined=9.08×10−4), including AS and non-AS (Pcombined =6.16×10−4 and Pcombined =0.049, respectively), whereas the -TTC haplotype was associated with reduced risk of SpA, including AS and non-AS (Pcombined=2.36×10−7, Pcombined=5.69×10−6 and Pcombined=2.13×10−4, respectively).

Conclusion: This is the first study to show an association between several polymorphisms located in ERAP1 and SpA as a whole. Our findings demonstrate consistent association of the same SNPs and haplotypes with both AS and non-AS subtypes of SpA.


Disclosure:

A. Kadi,
None;

B. Izac,
None;

R. Said-Nahal,
None;

A. Leboime,
None;

K. L. de Vlam,
None;

D. Elewaut,
None;

G. Chiocchia,
None;

M. A. Breban,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/investigating-the-genetic-association-between-erap1-and-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology